05/10/2024 7:30 AM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 4:00 PM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024 7:00 AM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 4:00 PM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/18/2024 12:45 PM | CLS Therapeutics, LLC (Filed by) Xenetic Biosciences (Subject) Xenetic Biosciences, Inc. (Subject)
| Form SC 13D/A | |
02/12/2024 8:15 AM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 4:16 PM | Mizrahy Moshe (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/18/2023 4:18 PM | Mizrahy Moshe (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 4:30 PM | EISENBERG JEFFREY F (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 4:30 PM | PARSLOW JAMES F (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 4:30 PM | Lockshin Curtis (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 4:30 PM | Logal Adam (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 4:30 PM | VINOGRADOV ALEXEY ANDREEVICH (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 4:30 PM | Callaway James Eric (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 4:30 PM | Dastoor Firdaus J. (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 4:30 PM | Borisenko Grigory G. (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 4:30 PM | Kornberg Roger D. (Reporting) Xenetic Biosciences (Issuer) Xenetic Biosciences, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 4:00 PM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 4:00 PM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form DEF 14A | |
11/13/2023 4:06 PM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form ARS | |
11/13/2023 7:30 AM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 11:21 AM | CLS Therapeutics, LLC (Filed by) Xenetic Biosciences (Subject) Xenetic Biosciences, Inc. (Subject)
| Form SC 13D/A | |
08/11/2023 7:05 AM | Xenetic Biosciences (Filer) Xenetic Biosciences, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 4:20 PM | CLS Therapeutics, LLC (Filed by) Xenetic Biosciences (Subject) Xenetic Biosciences, Inc. (Subject)
| Form SC 13D | |